Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A randomized, open-label, multiple dosing, three-way crossover clinical trial to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of evogliptin 5 mg and pioglitazone 30 mg after oral administration in healthy male subjects
Epistemonikos ID: 3ad06af0334df886082960c141304a949dcdd0f2
First added on: May 13, 2024